$0.24 $0.00 (0.0%)

03:38 PM EST on 01/28/20

Emerald Health Therapeutics, Inc. (NASDAQOTH:EMHTF)

CAPS Rating: 1 out of 5

Current Price $0.24 Mkt Cap $54.8M
Open $0.24 P/E Ratio 0.00
Prev. Close $0.24 Div. (Yield) $0.00 (0.0%)
Daily Range $0.23 - $0.24 Volume 31,274
52-Wk Range $0.23 - $0.29 Avg. Daily Vol. 511,492


This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

7 Outperform
9 Underperform

All-Star Players

0 Outperform
7 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQOTH:EMHTF Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

SmartAce (99.97)
Submitted September 19, 2018

Wife: Sarah's husband gives her flowers every day. I wish you'd do that!Me: Uh, okay.[next day]Me: (giving Sarah flowers) No, I don't get it either.



Fools bullish on NASDAQOTH:EMHTF are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about EMHTF.


Member Avatar kripibud (23.40) Submitted: 1/24/2019 2:11:36 AM : Outperform Start Price: $1.99 NASDAQ OTHER:EMHTF Score: -99.79

Medical clinics


Member Avatar RedondoBeachMike (36.25) Submitted: 1/16/2019 4:05:37 PM : Outperform Start Price: $2.20 NASDAQ OTHER:EMHTF Score: -115.07

Marijuana stock benefits from new agricultural law


Member Avatar Bigsef77 (67.66) Submitted: 1/14/2019 3:05:10 PM : Outperform Start Price: $3.91 NASDAQ OTHER:EMHTF Score: -105.63

Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada
GlobeNewswire•December 10, 2018

1.1 million square foot Pure Sunfarms facility steadily ramps capacity and production with industry-leading quality and yields in line with expectations

VICTORIA, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. ("Emerald" or the “Company”) (TSXV:EMH; OTCQX:EMHTF) announced that its 50%-owned joint venture for large-scale, low-cost, high-quality cannabis production, Pure Sunfarms, received from Health Canada the fifth amendment to its cultivation license for its 1.1 million square foot greenhouse in Delta, BC. With an added approximately 137,000 square feet (half of Quadrant 3), the total licensed cannabis production area is approximately 687,000 square feet. The newly licensed area is expected to be fully planted by the end of this week.

“Pure Sunfarms is already one of the largest licensed cannabis production facilities in the industry, and we expect completion of the conversion in Q1,” said Dr. Avtar Dhillon, Executive Chairman and President of Emerald. “With deep cannabis and large-scale greenhouse-growing expertise, established operational systems, and multiple cannabis strains being grown, Pure Sunfarms is achieving industry-leading quality and yields in line with our expectations. We expect this facility to be in full production in the first half of 2019, and aim for it to be one of the best cannabis production operations in the industry.

“Pure Sunfarms has delivered to Emerald contracted cannabis shipments that we are selling under the Emerald brand. It is also selling to other LPs, with favourable spot market pricing, as it awaits its packaging sales license to commence direct sales to provincial distributors. Pure Sunfarms continues to implement its plan to be a vertically integrated cannabis producer and marketer.”

Pure Sunfarms has completed conversion of the remainder of Quadrant 3 and is awaiting Health Canada approval for this additional approximately 138,000 square feet of production area. Pure Sunfarms expects to complete conversion of Quadrant 4 (approximately 275,000 square feet) by year end and anticipates Health Canada approval of that additional area by the end of January 2019. At a total licensed area of 1.1 million square feet, Pure Sunfarms’ Delta greenhouse will be one of the single largest cannabis growing facilities in the world.

All supplemental lighting is operational in Quadrants 2 and 3, and is expected to be operational in Quadrant 4 upon start of production, supporting maximum yields during the lower-daylight winter months. Supplemental lighting will be installed in Quadrant 1, which was completed as per plan earlier this year without supplemental lighting in order to permit immediate production during the summer months when supplemental lighting is not required. Quadrant 1 is expected to resume production by the end of February 2019.

The technologically-advanced Delta 3 greenhouse design is based on decades of large-scale, low-cost agricultural production experience and extensive cannabis expertise, resulting in a state-of-the-art facility with 16 grow rooms (eleven now licensed) optimized for year-round harvesting with more than 80 harvests annually.


Find the members with the highest scoring picks in EMHTF.

Score Leader


ClientNein (99.99) Score: +179.37

The Score Leader is the player with the highest score across all their picks in EMHTF.

Member Name Member
Call Time
Score Commentary
DrDoofenshmirtz 99.85 2/7/2019 Underperform 5Y $2.92 -91.96% +21.45% +113.41 0 Comment
zulabu 26.55 10/25/2018 Underperform 3M $2.57 -90.86% +22.31% +113.17 0 Comment
RayNobleEsq 99.98 10/24/2018 Underperform 5Y $2.76 -91.47% +21.24% +112.71 0 Comment
RyanCoke 99.92 2/11/2019 Underperform NS $2.63 -91.06% +20.81% +111.88 0 Comment
liszewski 99.96 11/12/2018 Underperform 5Y $3.50 -93.29% +17.98% +111.27 0 Comment
ClientNein 99.99 2/12/2019 Underperform 5Y $2.65 -91.12% +19.84% +110.95 0 Comment
DomJoao 88.98 11/29/2018 Underperform 1Y $2.50 -90.60% +19.16% +109.76 0 Comment
kdakota630 29.91 9/19/2018 Underperform 3M $3.85 -93.90% +12.31% +106.20 0 Comment
srkenne264 99.50 10/1/2018 Underperform 3M $3.79 -93.80% +11.95% +105.75 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. JordoTMF < 20 7/18/2019 Outperform 5Y $1.75 -86.57% +10.04% -96.61 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EMHTF.